BackTurn Therapeutics Overview

Turn Therapeutics Operating Income

Track Turn Therapeutics's operating income ($-6.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1246143.00

As of Mar 31, 2026

Annual Operating Income (TTM)

$-6719792.00

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Turn Therapeutics (TTRX) FAQ

Turn Therapeutics (TTRX) currently reports a operating income of $-6.7M as of March 2026. Use the charts on this page to explore Turn Therapeutics's operating income history and peer comparisons.

Turn Therapeutics reported $-6.7M in operating income as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-6.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turn Therapeutics, and consider following TTRX for alerts when major investors trade the stock.

Turn Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-6.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TTRX with unrelated industries.